[HTML][HTML] Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Background Understanding the level and characteristics of protection from past SARS-CoV-
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …
2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe …
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, multiple severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
F Liew, S Talwar, A Cross, BJ Willett, S Scott… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward …
limited insights into mucosal defences that prevent viral replication and onward …
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
Background Long-term effectiveness of COVID-19 mRNA boosters in populations with
different previous infection histories and clinical vulnerability profiles is inadequately …
different previous infection histories and clinical vulnerability profiles is inadequately …
Protection against reinfection with the omicron BA. 2.75 subvariant
H Chemaitelly, P Tang, P Coyle… - … England Journal of …, 2023 - Mass Medical Soc
Effect of Previous SARS-CoV-2 Infection against BA. 2.75 Infection A test-negative, case–
control study in Qatar showed that previous infection with pre-omicron strains of SARS-CoV …
control study in Qatar showed that previous infection with pre-omicron strains of SARS-CoV …
SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis
Background The higher hospitalisation rates of those aged 0–19 years (referred to herein as
'children') observed since the emergence of the immune-evasive SARS-CoV-2 Omicron …
'children') observed since the emergence of the immune-evasive SARS-CoV-2 Omicron …
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Summary Background Protection against SARS-CoV-2 symptomatic infection and severe
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
COVID-19 of previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination …
Hybrid immunity to SARS-CoV-2 from infection and vaccination—evidence synthesis and implications for new COVID-19 vaccines
JR Spinardi, A Srivastava - Biomedicines, 2023 - mdpi.com
COVID-19 has taken a severe toll on the global population through infections,
hospitalizations, and deaths. Elucidating SARS-CoV-2 infection-derived immunity has led to …
hospitalizations, and deaths. Elucidating SARS-CoV-2 infection-derived immunity has led to …
[HTML][HTML] Duration of BA. 5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection
D Planas, I Staropoli, F Porot, F Guivel-Benhassine… - Med, 2022 - cell.com
Summary Background Since early 2022, Omicron BA. 1 has been eclipsed by BA. 2, which
was in turn outcompeted by BA. 5, which displays enhanced antibody escape properties …
was in turn outcompeted by BA. 5, which displays enhanced antibody escape properties …
History of primary-series and booster vaccination and protection against Omicron reinfection
Laboratory evidence suggests a possibility of immune imprinting for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the differences in the …
syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the differences in the …